Susquehanna International Group’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $129K | Sell |
38,170
-5,053
| -12% | -$17K | ﹤0.01% | 5788 |
|
2025
Q1 | $167K | Buy |
43,223
+5,911
| +16% | +$22.8K | ﹤0.01% | 5615 |
|
2024
Q4 | $230K | Buy |
+37,312
| New | +$230K | ﹤0.01% | 5098 |
|
2024
Q3 | – | Sell |
-21,726
| Closed | -$72.8K | – | 5837 |
|
2024
Q2 | $72.8K | Buy |
21,726
+10,494
| +93% | +$35.2K | ﹤0.01% | 5187 |
|
2024
Q1 | $45.3K | Sell |
11,232
-9,664
| -46% | -$38.9K | ﹤0.01% | 5188 |
|
2023
Q4 | $55.4K | Sell |
20,896
-1,641
| -7% | -$4.35K | ﹤0.01% | 5527 |
|
2023
Q3 | $53.2K | Sell |
22,537
-34,257
| -60% | -$80.8K | ﹤0.01% | 5101 |
|
2023
Q2 | $358K | Sell |
56,794
-247,275
| -81% | -$1.56M | ﹤0.01% | 4034 |
|
2023
Q1 | $1.75M | Buy |
304,069
+279,613
| +1,143% | +$1.61M | ﹤0.01% | 2124 |
|
2022
Q4 | $251K | Buy |
24,456
+6,140
| +34% | +$63K | ﹤0.01% | 4143 |
|
2022
Q3 | $306K | Sell |
18,316
-5,588
| -23% | -$93.4K | ﹤0.01% | 4196 |
|
2022
Q2 | $335K | Buy |
+23,904
| New | +$335K | ﹤0.01% | 3847 |
|